Imricor Medical Systems, Inc (IMR) Stock Price & News

IMR:ASX

Imricor Medical Systems, Inc

A$1.31

-1.50%

(-0.020) 1D

Nov 13, 4:11:04 PM GMT+11 · AUD

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 13, 2026

Fiscal period

Q3 2026

- / -

Revenue / Est. (USD)

187.81K / -

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in USD

Loading Previous Earnings...

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	47.72K	12.32K	60.53K	187.81K
Cost of goods sold	757.07K	697.32K	732.50K	615.83K
Cost of revenue	757.07K	697.32K	732.50K	615.83K
Research and development expenses	2.70M	3.87M	3.68M	4.26M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.43M	3.31M	3.08M	3.49M
Operating expense	5.13M	7.18M	6.75M	7.75M
Total operating expenses	5.89M	7.88M	7.49M	8.36M
Operating income	-5.84M	-7.87M	-7.42M	-8.17M
Other non operating income	1.80M	-796.94K	259.20K	349.56K
EBT including unusual items	-6.09M	-12.57M	-7.38M	-2.91M
EBT excluding unusual items	-3.52M	-8.48M	-7.47M	-6.99M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-6.09M	-12.57M	-7.38M	-2.91M
Net profit margin	-12,759.82%	-102,007.68%	-12,195.01%	-1,549.25%
Earnings per share	-	-	-	-
Interest and investment income	349.20K	322.07K	377.53K	528.80K
Interest expense	-	-	-	-
Net interest expenses	349.20K	322.07K	377.53K	528.80K
Depreciation and amortization charges	-	-	-	-
EBITDA	-5.62M	-7.71M	-7.26M	-8.03M
Gain or loss from assets sale	12.12K	-	-	-420.00

Finance